Cardiac biomarker abnormalities are closely related to prognosis in patients with COVID-19

H Tuo, W Li, L Tang, B He, B Yao, P Mao… - International Heart …, 2021 - jstage.jst.go.jp
Summary Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is erupting and
spreading globally. Cardiovascular complications secondary to the infection have caught …

[HTML][HTML] Elevated cardiac biomarkers may be effective prognostic predictors for patients with COVID-19: A multicenter, observational study

J Yang, X Liao, W Yin, B Wang, J Yue, L Bai… - The American Journal of …, 2021 - Elsevier
Purpose The coronavirus disease 19 (COVID-19) has become a global health event.
Cardiac biomarkers like creatine kinase isoenzyme (CK-MB), myoglobin, and high …

Role of cardiac biomarkers in COVID-19: what recent investigations tell us?

S Khan, ST Rasool, SI Ahmed - Current Problems in Cardiology, 2021 - Elsevier
Purpose of review: Although the respiratory system is the main target of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), it is evident from recent data that other …

[HTML][HTML] Prognostic value of cardiac biomarkers in COVID-19 infection

A Sheth, M Modi, D Dawson, P Dominic - Scientific reports, 2021 - nature.com
Multiple Biomarkers have recently been shown to be elevated in COVID-19, a respiratory
infection with multi-organ dysfunction; however, information regarding the prognostic value …

[HTML][HTML] Cardiac biomarkers and COVID-19: A systematic review and meta-analysis

W An, JS Kang, Q Wang, TE Kim - Journal of Infection and Public Health, 2021 - Elsevier
Objective To systematically investigate the relationship between cardiac biomarkers and
COVID-19 severity and mortality. Methods We performed a literature search using PubMed …

[HTML][HTML] Cardiac biomarker levels and their prognostic values in COVID-19 patients with or without concomitant cardiac disease

JS Yu, NN Pan, RD Chen, LC Zeng… - Frontiers in …, 2021 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic has become a global threat. Increases
in cardiac biomarkers are common and are associated with adverse outcomes in patients …

[PDF][PDF] Cardiac biomarkers and mortality in COVID-19 infection: a review

A Cersosimo, G Cimino, L Amore… - … Archives for Chest …, 2023 - monaldi-archives.org
Lots of meta-analysis emphasize that a great number of hospitalized patients with moderate
and severe forms of COVID-19 developed acute myocardial damage, defined as an …

[HTML][HTML] Biomarkers associated with cardiovascular disease in COVID-19

CC Kaufmann, A Ahmed, AL Burger, M Muthspiel… - Cells, 2022 - mdpi.com
Coronavirus disease-19 (COVID-19) emerged late December 2019 in the city of Wuhan,
China and has since spread rapidly all over the world causing a global pandemic. While the …

[HTML][HTML] Prognostic value of cardiac biomarkers in COVID-19 infection: a meta-analysis

D Dawson, P Dominic, A Sheth, M Modi - Research square, 2020 - ncbi.nlm.nih.gov
Background Multiple Biomarkers have recently been shown to be elevated in COVID-19, a
respiratory infection with multi-organ dysfunction; however, information regarding the …

Risk stratification and prognosis prediction using cardiac biomarkers in COVID-19: a single-centre retrospective cohort study

M Sano, T Toyota, T Morimoto, Y Noguchi, R Shigeno… - BMJ open, 2024 - bmjopen.bmj.com
Objective There is a need for a robust tool to stratify the patient's risk with COVID-19. We
assessed the prognostic values of cardiac biomarkers for COVID-19 patients. Methods This …